Partners in Discovery
Partners in Discovery
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.
Harnessing the power of
science for our patients
Our doctors and researchers are turning today's
scientific discoveries into tomorrow's treatments.
Learn more about our research programs and initiatives.
Proven Track Record
A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.
Patients, Partners, Progress
Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.
Read their stories from Momentum magazine.
Cancer Center News
Latest news about our research, patient care programs, outreach and educational events.
Holowatyj named chair of scientific advisory board for ACPMP Research Foundation
Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.
VIGH, VICC establish cancer research program in Zambia
VUMC and the University of Zambia are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia and to encourage U.S.-based researchers to engage in cancer research in low- and middle-income countries.
Researchers find potential new target against colorectal cancer
Researchers at VUMC have discovered a potential new target in the fight against colorectal cancer, the nation’s third most common malignancy and, the second leading cancer killer.
VUMC’s Solórzano elected president-elect of AAES
Carmen Solórzano, MD, has been elected president-elect of the American Association of Endocrine Surgeons.
Pietenpol named chief scientific and strategy officer
Jennifer Pietenpol, PhD, is stepping down from her long-held role as the Cancer Center’s director to focus on a combined leadership role for VUMC as chief scientific and strategy officer.
Berlin named interim leader of Hematology and Oncology
Jordan Berlin, MD, has been appointed interim leader of the Division of Hematology and Oncology.